Cresco Labs (CRLBF) Debt Ratio (2020 - 2026)
Cresco Labs (CRLBF) posted Debt Ratio of 0.35 for Q1 2026, up 0.76% on a QoQ basis from 0.35 in Q4 2025.
Cresco Labs (CRLBF) Debt Ratio (2020 - 2026) Analysis & Trends
Cresco Labs' Debt Ratio history runs 7 years deep, the most recent figure standing at 0.35 for Q1 2026.
- Quarterly Debt Ratio changed N/A year-over-year to 0.35 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.35 (changed N/A YoY) and the FY2025 annual result came in at 0.35, up 3880.73% from the prior year.
- Debt Ratio was 0.35 for Q1 2026 at Cresco Labs, up from 0.35 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.38 in Q4 2023 and bottomed at 0.01 in Q4 2022.
- A 5-year average of 0.28 and a median of 0.35 in 2026 frame the typical range for Debt Ratio.
- Annual changes were most pronounced in 2023 — Debt Ratio surged 5311.87% — and 2024, when it slumped 97.65%.
- Cresco Labs' Debt Ratio stood at 0.01 in 2022, then jumped by 5311.87% to 0.38 in 2023, then slumped by 97.65% to 0.01 in 2024, then jumped by 3880.73% to 0.35 in 2025, then gained by 0.76% to 0.35 in 2026.
- Business Quant data shows CRLBF's Debt Ratio at 0.35 in Q1 2026, 0.35 in Q4 2025, and 0.01 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 0.26 |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.42 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.60 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.29 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 0.10 |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.39 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.29 |
| 10 | Cresco Labs | 254.96 Mn | 99.57 Mn | 75.45 Mn | 0.35 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.35 |
| Dec 31, 2025 | 0.35 |
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | 0.36 |
| Jun 30, 2024 | 0.37 |
| Mar 31, 2024 | 0.37 |
| Dec 31, 2023 | 0.38 |
| Dec 31, 2022 | 0.01 |
| Mar 31, 2022 | 0.31 |
| Dec 31, 2021 | 0.27 |
| Mar 31, 2021 | 0.21 |
| Dec 31, 2020 | 0.23 |